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In IPC-81 cells, the adenylyl-cyclase activation by cholera toxin produces an elevation of CAMP that causes a rapid cytolysis. A resistant clone 
with deficient cholera toxin-induced cyclase activity (yet sensitive to CAMP) showed a rapid decrease in the amount of membrane-bound Gsa (4247 
kDa) detectable soon after ADP-ribosylation of these proteins; pertussis toxin-sensitive G proteins (41 kDa) were not affected. Resistant cells 
showed a rapid decrease of Gsa that is consistent with the finding that CAMP did not accumulate in these cells. Cholera toxin treatment of resistant 
cells had long-lasting effects (several weeks) on the level of Gsa in the cell membrane. The duration of Gsa decrease does not correspond to the 
probable life of catalytically active cholera toxin in the cells, and suggests aregulated process more complex than a proteolytic degradation targeted 
on ADP-ribosylated molecules. 
Adenylyl-cyclase; GTP-binding protein; Down-regulation 
1. INTRODUCTION 
G proteins are essential for coupling many in- 
tracellular signals generated by activated membrane 
receptors to intracellular effector enzymes and ion 
channels [l-S]. Numerous signals transduced through 
the AC-CAMP-protein kinase A pathway play key roles 
in regulating hematopoiesis. In myeloid cells, CAMP as 
a result of cholera toxin (CT)-induced AC activation, 
provides a potent intracellular signal for differentiation 
and negative growth regulation [6-131. 
Previously, we isolated a myeloid leukemia (IPC-81) 
for which CT treatment generated a sustained AC ac- 
tivation that blocked cell proliferation and induced a 
rapid CAMP-dependent cytolysis [ 14,151. Interestingly, 
the rapid eradication of sensitive cells by cytolysis pro- 
moted the emergence of a few CT resistant clones. 
Though they were cultured for months in presence of 
CT, these cells were sensitive to CAMP analogs. The 
functional defect was located at the level of the AC en- 
zymic complex [ 161. 
It has been observed that some lineages of normal or 
leukemic cells, despite normal sensitivity to CAMP, are 
refractory to CT-induced proliferation inhibition. This 
implies some alteration in the response to CT of the G 
protein-cyclase complex. CT stabilizes the GTP-bound 
conformation of Gscu and decreases its GTPase activi- 
ty, mimicking receptor-G% coupled intracellular 
signalling and increasing AC activity [4]. Yet, the 
mechanisms by which cells, after CT exposure, switch 
AC from the active to the inactive state, remain 
unclear. 
In this paper, we show that CT resistant cells respond 
to CT exposure with a rapid decrease of Gscu membrane 
proteins; it was noticed that the long-lasting effects of 
CT exposure on GSCY did not correspond to the pro- 
bable intracellular life of CTa chain. 
2. MATERIALS AND METHODS 
2.1. Ceils 
Correspondence address: M. Lanotte, INSERM U301, Centre G. 
Hayem, HBpital St Louis, 1 Rue Vellefaux, F-75010 Paris, France 
An in vitro adapted cell line, IPC-81 [14], was isolated from the rat 
myeloid leukemia (BNML), and cultured in RPM1 medium sup- 
plemented with 10% horse serum. Two clones are grown in our 
laboratory: CTs and CTr cells which are CT-sensitive and CT- 
resistant, respectively [16]. The S49 cyc-mutant of the S49 rat lym- 
phoma, a Gscr deficient cell line [17] was provided by Dr J. Bockaert 
(Montpellier, France). 
2.2. Membrane preparation 
* Present address: Molecular Pathophysiology Branch, NIDDK/ 
NIH, Bethesda, MD, USA 
Abbreviations: CT, cholera toxin; PT, pertussis toxin; CTs cells, 
cholera toxin-sensitive cells; CTr cells, cholera toxin-resistant cells; 
AC, adenylyl-cyclase; SDS-PAGE: sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis 
lo8 cells were washed 3 times in Tris-HCl (10 mM, pH 7.4) with 
0.25 M sucrose, 2 mM MgClz, 1 mM CaClz, 10 mM KC1 and 0.10 
mg/ml leupeptin (buffer A), then frozen at -80°C and thawed twice, 
and homogenized with a Kontes potter. The homogenate was cen- 
trifuged (2500 x g, 4”C, 20 min) to remove the nuclei. The superna- 
tant was collected and centrifuged at 2lOOOxg, at 4”C, for 30 min. 
The pellet (semi-purified membranes) was resuspended in Tris-HCl 
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(10 mM, pH 7.4) with 0.25 M sucrose, and leupeptin (0.10 mg/ml) 
(buffer B). Proteins were determined by the method of Lowry [l&X]. 
2.3. ADP-ribosylation assay 
ADP-ribosylation was carried out on semi-purified membranes, as 
described by Berthillier et al. [19] and Jacquemin et al. [20]. ‘*P- 
labelled membrane proteins were analysed on a 10070 SDS-PAGE 
[21], followed by autoradiography and microdensitometric scanning 
of films. For quantitative measurements, 50 pg of ADP-ribosylated 
membranes, resuspended in 50 pl of ice-cold buffer B, were deposited 
on 3MM Whatman filters, then precipitated in 10% TCA at 4°C 
overnight. Filters were washed twice with ice-cold TCA 5%, then 
with ethanol/ether (l:l), dried and counted. ADP-ribosylation by 
pertussis toxin was carried out with 1 pg toxin for 100 pg membrane 
following the same procedure [20], except that the GTP concentra- 
tion was 0.1 mM and nicotinamide was omitted. 
2.4. Adenylyl cyclase activity assay 
Membranes (U-30 fig) were incubated in 100 ~1 of 25 mM Tris-HCl 
(pH 7.5) containing 5 mM MgCl2, 20 mM creatine phosphate, 100 
u/ml creatine phosphokinase, 1 mM [(Y-~‘P]ATP (50 cpm/pmol), 
lo- 6 M GTP for 20 min at 37°C. GTPrS (Sigma) was added as in- 
dicated. The reaction was stopped by addition of 100 81 of a solution 
containing 2% SDS, 40 mM ATP, 1.4 mM CAMP (pH 7.5). 20000 
cprn of [3H]cAMP and 800 pl Hz0 were added to each sample and 
[ *PIcAMP was isolated by ion-exchange chromatography by the 
method of Salomon et al. [22]. ‘H-counts were used to evaluate 
CAMP recovery. Assays were carried out in triplicate. 
2.5. Immunoblotting with Gscr antiserum 
Gs antisera (‘RM’ and ‘CSl’) were obtained in rabbit after 
repeated immunization with a conjugate of Keyhole Limpets Hemo- 
cyanin and a synthetic peptide corresponding to the RMHLRQYELL 
C-terminal sequence of GSa [23,34]. 100 gg membrane proteins were 
separated on a 10% or 12.5% SDS-PAGE [21] and transferred to 
nitrocellulose membranes. The blots were washed twice in buffer C 
(10 mM Tris-HCI, pH 7.5, with 500 mM NaCI) with 5% fat-free dry 
milk (30 min each), then incubated overnight at 20°C with Gsol an- 
tiserum (dilution l/300) in buffer C with 5% fat-free dry milk. The 
blots were then washed repeatedly with buffer C and incubated with 
[“‘I]Protein A (100 000 cpm/ml) in 50 ml buffer C with 5% fat-free 
dry milk for 45 min at 20°C. The blots were then washed and dried 
before autoradiography. 
2.6. Gsol functional assay 
Cell membranes (5 mg/ml) were extracted with 1% Na-cholate and 
Gsol activity in the extract was evaluated by its ability to complement 
the Gscr deficiency of S49 cyc-membranes invitro [17,22,23]. The Na- 
cholate extract from CTr cells (100 ~1) was added to cyc-membranes 
(100 kg) and incubated at 30°C for 20 min with GTP (100 PM); CTs 
cell membranes were used as a control. Na-cholate extracts were cen- 
trifuged (100 000 xg, 10 min, 4°C) and the pellets resuspended in 100 
~1 of buffer B and tested for AC activity. 
3. RESULTS 
Our previous studies concerning the IPC-81 CT- 
resistant cells (CTr) have shown a deficient AC activity 
associated with CT treatment [16]. Cells were resistant 
to high doses of CT, while they were sensitive to pro- 
staglandins (PGEi.2) and CAMP analogs. This work 
implied that a specific AC anomaly was involved, and 
presumably concerned Gscu, Gsa ADP-ribosylation, or 
activation of the catalytic subunit by Gscr. Here, we 
studied the feature of Gsa! in sensitive or resistant cells 
and the effects of prolonged exposure of these cells to 
CT. 
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3.1. ADP-ribosylation of Gsa! and Giol by cholera and 
pertussis toxins 
CT-resistant cells (CTr), selected by a long-term ex- 
posure to CT, were washed and grown for 7 days 
without CT. This allowed about 10 cell cycles and a lo3 
clonal cell expansion in the absence of CT. Membranes 
from both sensitive (CTs) and resistant (CTr) cells were 
prepared. ADP-ribosylation of G proteins in CTr and 
CTs cell membranes by CT was measured (Fig. 1A). 
The CTs ADP-ribosylated membranes revealed 
radioactive bands (47 kDa and 42 kDa) corresponding 
to the Gscu protein subunits. CTr membranes were 
significantly deficient in Gsa! protein ADP-ribosylation 
(Fig. 1A). Both CTs and CTr cells, when preincubated 
for 4 h with CT IO-* M prior to the ADP-ribosylation 
assay, showed no ADP-ribosylation (not shown). CTs 
cell Gstv protein GDP-ribosylation is about 8 times 
higher than CTr cell ADP-ribosylation (CTs = 1.30 
pmol [32P]NAD/mg protein; CTr = 0.18 pmol 
[32P]NAD/mg protein). After subtraction of the non- 
specific radioactivity, densitometry measurements 
revealed an even greater difference in ADP- 
ribosylation (CTs/CTr = 9.7). The ADP-ribosylation 
by pertussis toxin (PT) showed (Fig. 1B) a prominent 
41 kDa band in both CTr and CTs cells; labellings were 
approximately equal in sensitive and resistant cells. The 
minor 38 kDa band suggests a partial degradation of 
Gia! during the procedure. 
3.2. Immunoblotting with Gs antiserum 
The expression of Gscu in CTs, CTr cells and the ef- 
fects of chronic exposure of CTr cells to CT were 
studied. CTs and CTr cells did express roughly similar 
amounts of Gsa! (47 kDa and 42 kDa); CT treatment of 
CTr over 7 days resulted in undetectable amounts of 
Gscu both in membrane and cytosol (Fig. 2A,B). The 
kinetics of Gscu decrease upon CT treatment was 
analysed (Fig. 2C). In CTs cells treated with CT, the 
A& of Gsa (both subunits) increased after 30 min (43 
kDa and 49 kDa, respectively) as a consequence of 
ADP-ribosylation, After 4 h of CT treatment, the 
amount of Gsa! decreased mainly in the 43 kDa band. 
After 6 h, studies on Gscu in these cells were com- 
plicated by the process of cytolysis; studies on cell 
clones refractory to cytolysis indicated that the two Gscr 
subunits became totally undetectable after 12-15 h of 
treatment (not shown). In CTr cells, a shift to higher 
M, of Gscu subunits corresponding to ADP- 
ribosylation was similarly observed. Gscu was rapidly 
lost after l-2 h of CT treatment: it was nearly undetec- 
table after 4-6 h (Fig. 2C). The phenomenon affected 
first the 47-49 kDa subunit and later the 42-43 kDa 
subunit. The time required for CT-treated CTr cells 
grown in CT-free medium to recover the normal Gsa! 
amount was surprisingly long. After 7-15 days of 
culture in CT-free medium, Gscu were expressed again 
and had M, corresponding to the non-ADP-ribosylated 
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Fig. 1. Membrane Gso and Gia! protein ADP-ribosylation in CTs and CTr cells in presence of cholera or pertussis toxins. Cells were cultured 
without CT for two weeks before the ADP-ribosylation assays. (a) ADP-ribosylation by CT: (A) CTs cells, microdensitometer scanning; (B) CTs 
cells, autoradiography; (C) CTr cells, autoradiography; (D) CTr cells, microdensitometer scanning (ordinates indicate arbitrary units used for 
densitometric measurements). (b) ADP-ribosylation by PT: (A) CTs cells, autoradiography; (B) CTr cells, autoradiography. 
molecules (42 kDa and 47 kDa). The intensity of these 
bands was, however, much lower than in CTs cells. 
Normal levels were found after 20-30 days, on average. 
3.3. Adenylyl cyclase activity 
AC in cell membranes was evaluated to find a cor- 
relation between this activity, the level of Gscll and the 
resistance to CT. We analysed: (i) CTr cells cultured in 
presence of CT (no Gscr detected by immunoblotting), 
(ii) CTr cells after several weeks of culture in CT-free 
medium (normal level of GSCY), and (iii) CTs cells as the 
control (normal level of GSCY). As shown in Table I, AC 
activity stimulated by GTPyS is significantly lower for 
CT-treated CTr cells; the GTPyS-dependent AC activi- 
ty was recovered in CTr cells cultured in CT-free 
medium, as cells re-expressed GSCY (Fig. 2D). 
3.4. Reconstitution of Gscx function in S49 cyc- ceN 
membranes 
Complementation of S49 cyc- cell membranes with 
membrane extracts free of AC activity was previously 
used to detect functional Gscr molecules [26]. 
Reconstitution of S49 cyc- membranes with extracts of 
CTr cells treated with CT, have no significant amount 
of functional Gsol (Table II). This result corroborates 
the absence of Gslv on immunoblots (Fig. 2), and the 
low AC activity (Table I). CTr cell membranes, in this 
experiment, showed a low level of functional Gsa 
(basal and GTPyS-dependent) compared to CTs cell 
membranes; this situation is typical of CTr cells during 
B *-I-* c-l-r 
c-rr/ct s-l-* + ct c-p-r + Et 
n. c. n. 0. n. c. Y. c. n. c. 
Fig. 2. Immunoblotting with anti-Gscr abbit antiserum, after SDS- 
PAGE. (A) Gscu expression in CTs cells (CTs) and CTr cells (CTr): 
one week (1), two weeks (2), one month (3) after the cessation of CT 
treatment; S49 cyc- cells (Cyc-). (B) Gso expression at the membrane 
(M.) and in cytosol (C.) CTr/CT: CTr cells cultured for 7 days with 
lo- * M CT; CTs + ct and CTr + ct : CTs and CTr cells respectively, 
incubated for 5 h with 10-s M CT. (C) Kinetics of Gscr decrease 
during CT treatment of CTs and CTr cells. (D) Re-expression of Gso 
in CTr cells after the cessation of CT treatment. 
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Table I 
Adenylyl cyclase activation by GTPyS: Differences between cell types 
Adenylyl cyclase activity in IPC-81 cells 
(pmol [“P]cAMP/min/mg protein) 
CTs CTr CTr/CT 
Basal 254 * 41 149 f 3 197 Z!Z 7
GTPrS 1289 * 171 1345 f 48 477 + 75 
CTr/CT cells were cultured for a week with CT (lo-* M), then wash- 
ed 3 times before membrane preparation (CTrKT); control, CTr 
cells (CTr) were cultured for at least two weeks in CT-free medium. 
Adenylyl cyclase activity of 20 fig membrane, stimulated (or not = 
basal) with GTPyS was measured after a 20 min incubation (37V). 
Table II 
Titration of Gscu activity by reconstitution of S49 cyc- cell membranes 
Adenylyl cyclase activity in S49 cyc- membrane 
reconstituted with IPC-81 membrane cholate extracts 
(pmol [“PIcAMP/ pg protein) 
CTs CTr CTr/CT s49 cyc- 
Basal 106 f 12 57 + 7 72 XL 3 41 f 31 
GTPyS 1013 f 9 436 * 10 42 + 4 48 f 4 
S49 cyc- cell membranes were prepared as described. Cholate extracts 
(100 ~1; 100 pg protein, from 5 mg of membrane) were added to 100 
pg S49 cyc- cell membrane and incubated as described, before titra- 
tion of AC activity at 37°C for 20 min. 
the first weeks that followed the cessation of CT 
treatment. 
4. DISCUSSION 
Previous work using the CT-sensitive IPC-81 cell line 
has shown that rare CT-resistant clones can be selected 
by prolonged exposure to CT [16]; CTr cells still re- 
spond by cytolysis to PGE mediated AC activation and 
CAMP analogs, hence suggesting a functional defect 
related to AC activation by CT. 
In this paper, we demonstrate that, despite low or 
undetectable levels of ADP-ribosylated Gscu proteins 
found after prolonged exposure to CT, the AC defect 
cannot be explained by decreased ADP-ribosylation. 
Other results support this conclusion: CTr cells 
cultured for several weeks or a month in CT-free media 
showed CT mediated ADP-ribosylation of two protein 
bands (43 kDa and 49 kDa), subsequently im- 
munocharacterized as Gscu by two distinct anti-G% an- 
tisera. The shift of K related to ADP-ribosylation was 
clearly observed on GSCY Western-blots. 
Immunoblotting experiments with anti-GscY antisera 
(Fig. 2) revealed that the treatment of CTr cells with CT 
resulted in a rapid decrease of Gsol labelling after ADP- 
ribosylation, down to undetectable levels (5 h), while in 
CTs cells Gsa! was still titrable, when the CAMP- 
induced cytolysis proceeded (8 h). The phenomenon 
was clearly restricted to Gscu; neither GiaADP- 
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ribosylation by PT was affected (Fig. l), nor Gicu ex- 
pression decreased - as indicated by anti-Gia! antiserum 
titration (not shown). In conclusion, CT-mediated 
decrease of Gscu can explain the absence of ADP- 
ribosylation following CT treatment, and the low AC 
activity, a phenomenon sufficient to avoid CT- 
mediated cytolysis; it also explains why CAMP- 
dependent cytolysis remains. 
Recently, Chang and Bourne described the pro- 
gressive disappearance of Gscu with CT treatment in 
GH3 cells [27]. However, in these cells the decrease of 
Gscu was not accompanied by a complete loss of CT- 
induced AC activity. The authors conclude that CT 
treatment increases the susceptibility of GSCY to pro- 
teolytic degradation. Milligan et al. [24] have 
demonstrated a CAMP-independent down-regulation 
of GSCY, but not of Gicu by CT treatment of L6 skeletal 
myoblasts. This down-regulation occurred subsequent 
to CT catalysed ADP-ribosylation. MacLeod and 
Milligan recently demonstrated [28] that a biphasic 
regulation of AC activity by CT in neuroblastoma x 
glioma hybrid cells is due to the activation and subse- 
quent loss of the (Y subunit of Gs. 
In IPC-81 cells, CT induces Gsa decrease by 
mechanisms which are probably similar. In CTs cells, 
while GSCX degradation proceeds, the AC activity re- 
mains, high enough to irreversibly damage cells 
through intracellular CAMP elevation. On the contrary, 
in CTr cells GSCY degradation is enhanced to the point 
that AC generates inoperative CAMP levels. CAMP 
treatments of IPC-81 cells neither modify Gscu levels 
(Western blots) nor Gscr ADP-ribosylation (data not 
shown); this confirmed previous reports [27,28] that 
Gscl! decrease by CT is a CAMP-independent process. 
An interesting result is that CTr cells retain the mark of 
CT treatment for a considerable time (up to 2 weeks, 
i.e. 20 cell cycles on average). These data argue against 
the presence of still active CT molecules in the cell at 
that time. ADP-ribosylation by CT, as proposed by 
others [24,27,28] may serve to target GSCY molecules for 
degradation by proteases, but the process is certainly 
more complex; differences in the kinetics of Gsa 
decrease, between the two cell clones analyzed herein 
and also between two Gsa, isoforms, remain unex- 
plained. 
The questions addressed by our results are whether 
or not some particular structure or conformation of 
Gscr confers an increased stability to CTs Gscr 
molecules (or confers unstability to CTr Gscu), or 
whether CT has the capacity to turn on some 
physiological process for post-translational down- 
regulation or turnover of Gsa. The studies of these cells 
should tell us more about these regulatory processes. 
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